Expressivity of a common fragile site, fra(3)(p14.2), in patients with cancer and other diseases
- 1 September 1992
- journal article
- Published by Springer Nature in Journal of Human Genetics
- Vol. 37 (3) , 205-213
- https://doi.org/10.1007/bf01900714
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A population cytogenetic study of a common fragile site, fra(3)(p14), in a healthy populationJournal of Human Genetics, 1990
- No difference in expression of chromosomal fragile sites in patients with solid malignant tumours and normal controlsGenes, Chromosomes and Cancer, 1990
- Tumor Suppressor Genes: The Puzzle and the PromiseScience, 1989
- Patients with different lung cancers show normal expression of fra(3)(p14.2) in aphidicolin-treated lymphocyte culturesCancer Genetics and Cytogenetics, 1989
- Common fragile sites in chromosomes of bone marrow cells and peripheral blood lymphocytes from healthy persons and leukemia patientsCancer Genetics and Cytogenetics, 1989
- Effects of folate in culture medium on common fragile sites in lymphocyte chromosomes from normal and leukemic childrenHuman Genetics, 1988
- Translocation t(3;8)(p14.2;q24.1) in renal cell carcinoma affects expression of the common fragile site at 3p14(FRA3B) in lymphocytesCancer Genetics and Cytogenetics, 1988
- Common fragile sites: Their prevalence in subjects with constitutional and acquired chromosomal instabilityAmerican Journal of Medical Genetics, 1987
- DNA polymerase ? inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomesHuman Genetics, 1984
- Maximum utilization of the life table method in analyzing survivalJournal of Chronic Diseases, 1958